prescription drug benefits

Employers Grapple with Claims Costs versus Outcomes of GLP-1 Drugs

Anne Patterson
 

A new survey report from the International Foundation of Employee Benefit Plans reveals U.S. employer coverage and considerations surrounding glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes. These drugs were also found to cause weight loss and have […]

RxDC Reporting Will Bring Changes . . . Here’s What to Know Now

Jonas Leyrer, CEBS
 

Late last year, Congress passed the Consolidated Appropriations Act, 2021 (CAA), which contained a provision requiring health care plans to submit Prescription Drug Data Collection (RxDC) reports to CMS. RxDC was made retroactive for 2020 but its implementation was delayed for a […]

18 Prescription Drug Cost-Containment Strategies For Your Plan

18 Prescription Drug Cost-Containment Strategies For Your Plan

Justin Held, CEBS
 

Benefits practitioners have grown accustomed to headlines addressing the escalating costs of prescription drug spending. Despite concerted efforts, the cost of commonly prescribed brand-name drugs continues to grow at alarming rates. A recent study from the University of Pittsburgh stated that over […]

Organizations Face New Health and Retirement Benefit Implications Due to COVID-19

Organizations Face New Health and Retirement Benefit Implications Due to COVID-19

Anne Patterson
 

How has the COVID-19 pandemic impacted employee benefits? The International Foundation has been tracking implications for workplaces across the country, providing a snapshot of the difficult decisions employers and their workers are making regarding their retirement and health care benefits. The latest […]